Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KCNA3 | P22001 | 5/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19686107 | 0.95 | MEN1 (0.35) | MEN1KMT2AKCNA3KDM4EUSP2 | |
| SCHEMBL19685899 | 0.88 | KDM4E (0.32) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL19686105 | 0.84 | KDM4E (0.32) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL19686012 | 0.83 | ALDH1A1 (0.42) | MEN1KMT2AKCNA3KDM4EUSP2 | |
| SCHEMBL19686253 | 0.83 | MEN1 (0.35) | MEN1KMT2AKCNA3KDM4EUSP2 | |
| SCHEMBL19686062 | 0.81 | MEN1 (0.35) | MEN1KMT2AKCNA3KDM4EALDH1A1 | |
| SCHEMBL19686021 | 0.79 | BRD4 (0.40) | MEN1KMT2A | |
| SCHEMBL19686056 | 0.79 | MEN1 (0.35) | MEN1KMT2AKCNA3KDM4EUSP2 | |
| SCHEMBL19685987 | 0.77 | ESR1 (0.36) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL19685859 | 0.77 | BRD4 (0.43) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | CYC1, CCNA1, CYCS | MEN1 644/4885KMT2A 1444/4885KCNA3 677/4885 |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | CYC1, CCNA1, CYCS | MEN1 644/4885KMT2A 1444/4885KCNA3 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.